Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001284
Filing Date
2025-01-10
Accepted
2025-01-10 16:55:07
Documents
1
Period of Report
2025-01-07

Document Format Files

Seq Description Document Type Size
1 form4-01102025_040103.html 4  
1 form4-01102025_040103.xml 4 6193
  Complete submission text file 0001415889-25-001284.txt   7706
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Issuer) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address
See Tai Sandi (Reporting) CIK: 0002009350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41855 | Film No.: 25523692